Adult antiandrogen treatments for female acne block hormone signals in oil glands to lower oil and breakouts. Adult trials in women show benefit, but teens with inflammatory acne have strong backing only for a topical option from age 12.
Antiandrogen means a drug that weakens androgen effects on skin. Inflammatory acne means red, tender bumps and pus-filled spots. Adult designs help teens ask better questions, without assuming the same result.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the adult trials test?
- How do these hormone-based treatments work?
- Why are teen results more limited?
- What safety checks should families discuss?
What did the adult trials test?
The NIHR Journals Library describes SAFA as a pragmatic multicentre double-blind trial that randomized 410 women with persistent facial acne to spironolactone plus topical therapy or placebo plus topical therapy, starting at 50 mg daily and rising to 100 mg the SAFA trial report. Both groups kept a topical routine, so the test measured added benefit from the pill.
Symptom scores for acne-related quality of life improved more with spironolactone than placebo in that program. Separation was larger at 24 weeks than at 12 weeks, and 71% versus 43% reported overall improvement, according to a BMJ appraisal summarized on PubMed Central.
How do these hormone-based treatments work?
Spironolactone blocks androgen-receptor binding and 5-alpha-reductase activity in sebaceous glands, which lowers sebum, according to Cutis experts. Less oil means fewer clogged pores and less fuel for inflamed lesions. Experts state the systemic antiandrogen effect limits oral use to women, with 50-100 mg daily effective for acne.
Topical action is more local. Clascoterone 1% cream blocks androgen receptors in skin, with limited absorption beyond skin. That local approach allows use in both males and females.
Why are teen results more limited?
The Inserm team reports FASCE randomized 133 adult women with moderate acne to spironolactone 150 mg daily for 6 months or doxycycline 100 mg daily for 3 months then placebo, both with benzoyl peroxide, with superior Investigator Global Assessment success for spironolactone the FASCE trial document. The result applies to adult women with moderate acne, not to younger teens with severe inflammatory disease. Support for systemic spironolactone in teens rests on small retrospective series, not large teen trials.
Cutis reviewers note spironolactone is not FDA-approved for acne, with adolescent data such as 68% improvement in 73 patients age 19 and younger and 80% improvement in 80 adolescent females the Cutis practical review. Small chart reviews cannot control dose, topical use, or acne type. Age rules also differ by product:.
- clascoterone 1% cream is FDA-indicated for acne vulgaris at 12 years and older, applied twice daily, per the FDA label the Winlevi prescribing label
- combined pills for acne require menarche and desire for birth control, with norgestimate pills for moderate acne at 15 years and older and drospirenone pills at 14 years and older
- systemic spironolactone for teen acne remains off-label and needs direct medical selection
What safety checks should families discuss?
Pregnancy risk is the main practical limit for systemic spironolactone. The drug crosses the placenta and caused feminization of male fetuses in animals, so patients should avoid it during pregnancy and use contraception, according to the BMJ. A baseline kidney and potassium check is advised, while routine repeat testing is unnecessary in young healthy women.
For a visit, bring puberty history, birth-control needs, current topicals, blood pressure drugs, potassium supplements, and plans for pregnancy. Ask whether a twice-daily topical, a birth-control pill with an acne indication, or continued topical plus benzoyl peroxide fits the teen's acne type and age. Do not start a systemic antiandrogen to copy an adult trial result.
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: Study Design and Evidence Limits for Teens With Inflammatory Acne
- Limited Topical Spironolactone Evidence in the 2026 Review: Study Design and Evidence Limits for Teens With Inflammatory Acne
- Topical Clascoterone Evidence Revisited in 2026: Study Design and Evidence Limits for Teens With Inflammatory Acne